US Stock MarketDetailed Quotes

AMGN Amgen

Watchlist
  • 269.380
  • -3.630-1.33%
Close Apr 25 16:00 ET
  • 267.360
  • -2.020-0.75%
Post 18:25 ET
144.49BMarket Cap21.57P/E (TTM)

Amgen Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
7.09%28.19B
19.84%8.2B
3.77%6.9B
5.94%6.99B
-2.13%6.11B
1.32%26.32B
-0.10%6.84B
-0.81%6.65B
1.04%6.59B
5.71%6.24B
Operating revenue
8.50%26.91B
19.55%7.83B
4.99%6.55B
6.40%6.68B
2.01%5.85B
2.07%24.8B
4.48%6.55B
-1.31%6.24B
2.73%6.28B
2.49%5.73B
Cost of revenue
31.92%8.45B
78.13%3.11B
13.73%1.81B
20.07%1.81B
10.19%1.72B
-0.74%6.41B
1.69%1.75B
-1.31%1.59B
-7.76%1.51B
4.77%1.56B
Gross profit
-0.89%19.74B
-0.16%5.08B
0.65%5.1B
1.75%5.17B
-6.24%4.39B
2.01%19.92B
-0.70%5.09B
-0.65%5.06B
3.99%5.08B
6.03%4.68B
Operating expense
14.40%11.84B
33.23%3.81B
27.95%3.08B
-14.41%2.49B
13.18%2.46B
-0.29%10.35B
1.35%2.86B
-11.59%2.4B
13.77%2.91B
-4.60%2.18B
Selling and administrative expenses
14.13%6.18B
44.66%2.27B
5.13%1.35B
-2.49%1.29B
2.44%1.26B
0.86%5.41B
10.32%1.57B
-1.38%1.29B
-4.12%1.33B
-2.07%1.23B
Research and development costs
7.89%4.78B
15.86%1.53B
-2.97%1.08B
7.12%1.11B
10.32%1.06B
-7.99%4.43B
-1.78%1.32B
-21.80%1.11B
-3.97%1.04B
-0.83%959M
Other operating expenses
74.75%879M
114.71%5M
12,780.00%644M
-84.87%82M
1,580.00%148M
159.28%503M
-166.67%-34M
162.50%5M
502.22%542M
-116.39%-10M
Operating profit
-17.45%7.9B
-43.00%1.27B
-24.02%2.02B
23.35%2.68B
-23.16%1.92B
4.62%9.57B
-3.21%2.23B
11.86%2.66B
-6.73%2.18B
17.43%2.5B
Net non-operating interest income expense
-104.48%-2.88B
-97.83%-821M
-106.25%-759M
-129.27%-752M
-84.07%-543M
-17.46%-1.41B
-23.88%-415M
-24.32%-368M
-16.73%-328M
-3.51%-295M
Non-operating interest expense
104.48%2.88B
97.83%821M
106.25%759M
129.27%752M
84.07%543M
17.46%1.41B
23.88%415M
24.32%368M
16.73%328M
3.51%295M
Other net income (expense)
448.03%2.83B
700.00%402M
585.00%685M
-0.32%-318M
489.43%2.06B
34.67%-814M
-141.36%-67M
36.99%100M
78.78%-317M
-4,176.92%-530M
Special income (charges)
--0
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
448.03%2.83B
700.00%402M
585.00%685M
-0.32%-318M
489.43%2.06B
-414.29%-814M
-141.36%-67M
36.99%100M
-2,981.82%-317M
-4,176.92%-530M
Income before tax
6.93%7.86B
-51.26%852M
-18.60%1.95B
5.42%1.61B
105.49%3.44B
9.63%7.35B
-17.97%1.75B
11.00%2.39B
174.37%1.53B
-9.80%1.68B
Income tax
43.32%1.14B
-35.61%85M
-12.85%217M
9.81%235M
202.01%601M
-1.73%794M
-43.10%132M
-8.12%249M
127.66%214M
-5.69%199M
Net income
2.52%6.72B
-52.54%767M
-19.27%1.73B
4.71%1.38B
92.48%2.84B
11.18%6.55B
-14.90%1.62B
13.75%2.14B
183.84%1.32B
-10.33%1.48B
Net income continuous Operations
2.52%6.72B
-52.54%767M
-19.27%1.73B
4.71%1.38B
92.48%2.84B
11.18%6.55B
-14.90%1.62B
13.75%2.14B
183.84%1.32B
-10.33%1.48B
Minority interest income
Net income attributable to the parent company
2.52%6.72B
-52.54%767M
-19.27%1.73B
4.71%1.38B
92.48%2.84B
11.18%6.55B
-14.90%1.62B
13.75%2.14B
183.84%1.32B
-10.33%1.48B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
2.52%6.72B
-52.54%767M
-19.27%1.73B
4.71%1.38B
92.48%2.84B
11.18%6.55B
-14.90%1.62B
13.75%2.14B
183.84%1.32B
-10.33%1.48B
Basic earnings per share
3.12%12.56
-52.65%1.43
-19.45%3.23
4.88%2.58
97.77%5.32
17.79%12.18
-10.65%3.02
20.78%4.01
203.70%2.46
-5.61%2.69
Diluted earnings per share
3.14%12.49
-52.67%1.42
-19.10%3.22
4.90%2.57
97.01%5.28
17.80%12.11
-10.71%3
20.24%3.98
202.47%2.45
-5.30%2.68
Dividend per share
9.79%8.52
9.79%2.13
9.79%2.13
9.79%2.13
9.79%2.13
10.23%7.76
10.23%1.94
10.23%1.94
10.23%1.94
10.23%1.94
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 7.09%28.19B19.84%8.2B3.77%6.9B5.94%6.99B-2.13%6.11B1.32%26.32B-0.10%6.84B-0.81%6.65B1.04%6.59B5.71%6.24B
Operating revenue 8.50%26.91B19.55%7.83B4.99%6.55B6.40%6.68B2.01%5.85B2.07%24.8B4.48%6.55B-1.31%6.24B2.73%6.28B2.49%5.73B
Cost of revenue 31.92%8.45B78.13%3.11B13.73%1.81B20.07%1.81B10.19%1.72B-0.74%6.41B1.69%1.75B-1.31%1.59B-7.76%1.51B4.77%1.56B
Gross profit -0.89%19.74B-0.16%5.08B0.65%5.1B1.75%5.17B-6.24%4.39B2.01%19.92B-0.70%5.09B-0.65%5.06B3.99%5.08B6.03%4.68B
Operating expense 14.40%11.84B33.23%3.81B27.95%3.08B-14.41%2.49B13.18%2.46B-0.29%10.35B1.35%2.86B-11.59%2.4B13.77%2.91B-4.60%2.18B
Selling and administrative expenses 14.13%6.18B44.66%2.27B5.13%1.35B-2.49%1.29B2.44%1.26B0.86%5.41B10.32%1.57B-1.38%1.29B-4.12%1.33B-2.07%1.23B
Research and development costs 7.89%4.78B15.86%1.53B-2.97%1.08B7.12%1.11B10.32%1.06B-7.99%4.43B-1.78%1.32B-21.80%1.11B-3.97%1.04B-0.83%959M
Other operating expenses 74.75%879M114.71%5M12,780.00%644M-84.87%82M1,580.00%148M159.28%503M-166.67%-34M162.50%5M502.22%542M-116.39%-10M
Operating profit -17.45%7.9B-43.00%1.27B-24.02%2.02B23.35%2.68B-23.16%1.92B4.62%9.57B-3.21%2.23B11.86%2.66B-6.73%2.18B17.43%2.5B
Net non-operating interest income expense -104.48%-2.88B-97.83%-821M-106.25%-759M-129.27%-752M-84.07%-543M-17.46%-1.41B-23.88%-415M-24.32%-368M-16.73%-328M-3.51%-295M
Non-operating interest expense 104.48%2.88B97.83%821M106.25%759M129.27%752M84.07%543M17.46%1.41B23.88%415M24.32%368M16.73%328M3.51%295M
Other net income (expense) 448.03%2.83B700.00%402M585.00%685M-0.32%-318M489.43%2.06B34.67%-814M-141.36%-67M36.99%100M78.78%-317M-4,176.92%-530M
Special income (charges) --0------------------0----------------
Other non- operating income (expenses) 448.03%2.83B700.00%402M585.00%685M-0.32%-318M489.43%2.06B-414.29%-814M-141.36%-67M36.99%100M-2,981.82%-317M-4,176.92%-530M
Income before tax 6.93%7.86B-51.26%852M-18.60%1.95B5.42%1.61B105.49%3.44B9.63%7.35B-17.97%1.75B11.00%2.39B174.37%1.53B-9.80%1.68B
Income tax 43.32%1.14B-35.61%85M-12.85%217M9.81%235M202.01%601M-1.73%794M-43.10%132M-8.12%249M127.66%214M-5.69%199M
Net income 2.52%6.72B-52.54%767M-19.27%1.73B4.71%1.38B92.48%2.84B11.18%6.55B-14.90%1.62B13.75%2.14B183.84%1.32B-10.33%1.48B
Net income continuous Operations 2.52%6.72B-52.54%767M-19.27%1.73B4.71%1.38B92.48%2.84B11.18%6.55B-14.90%1.62B13.75%2.14B183.84%1.32B-10.33%1.48B
Minority interest income
Net income attributable to the parent company 2.52%6.72B-52.54%767M-19.27%1.73B4.71%1.38B92.48%2.84B11.18%6.55B-14.90%1.62B13.75%2.14B183.84%1.32B-10.33%1.48B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 2.52%6.72B-52.54%767M-19.27%1.73B4.71%1.38B92.48%2.84B11.18%6.55B-14.90%1.62B13.75%2.14B183.84%1.32B-10.33%1.48B
Basic earnings per share 3.12%12.56-52.65%1.43-19.45%3.234.88%2.5897.77%5.3217.79%12.18-10.65%3.0220.78%4.01203.70%2.46-5.61%2.69
Diluted earnings per share 3.14%12.49-52.67%1.42-19.10%3.224.90%2.5797.01%5.2817.80%12.11-10.71%320.24%3.98202.47%2.45-5.30%2.68
Dividend per share 9.79%8.529.79%2.139.79%2.139.79%2.139.79%2.1310.23%7.7610.23%1.9410.23%1.9410.23%1.9410.23%1.94
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept CAR-T Therapy
CAR-T Therapy
Intraday-1.22%